SCHEMBL5281380

SCHEMBL5281380

Fc1cc[c]c(-c2cccs2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 5/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
HPGD P15428 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KCNH2 Q12809 1/20 0.34
ATM Q13315 1/20 0.34
GABRA1 P14867 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19127624 0.78 MAOA (0.38) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL10854744 0.78 ALDH1A1 (0.41) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL3941444 0.77 MEN1 (0.42) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL275868 0.76
SCHEMBL10849212 0.74 MAPT (0.39) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL126938 0.72 KDM4E (0.39) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL7152278 0.69 KDM4E (0.36) MAPTKDM4EALDH1A1NPC1RAB9A
SCHEMBL5093327 0.68 MAOB (0.35) MAPTKDM4EALDH1A1HPGDCYP1A2
SCHEMBL6103317 0.68 PDGFRB (0.42) MAPTALDH1A1CYP2C9CYP2C19KCNH2
SCHEMBL28045453 0.68 PDPK1 (0.39) ALDH1A1NPC1RAB9ACYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023076259-A1 TRIAZOLOPYRIDAZINE COMPOUNDS USEFUL AS RAC1 INHIBITORS REVERE PHARMACEUTICALS (US) 2023-05-04 WO disclosed
EP-3402335-A1 USE OF ACTIVE SUBSTANCES FOR CONTROLLING VIRUS INFECTION IN PLANTS Bayer CropScience Aktiengesellschaft (DE) 2018-11-21 EP disclosed
WO-2017121810-A1 USE OF ACTIVE SUBSTANCES FOR CONTROLLING VIRUS INFECTION IN PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-07-20 WO disclosed
EP-1448201-B1 N-(INDOLCARBONYL-)PIPERAZINE DERIVATIVES FOR THE TREATMENT OF OBESITY MERCK PATENT GMBH (DE) 2007-11-28 EP disclosed
EP-1539159-A1 SULPHONYLPIPERIDINE DERIVATIVES CONTAINING AN ARYL OR HETEROARYL GROUP FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS Astrazeneca AB (SE) 2005-06-15 EP disclosed
WO-2004006926-A1 SULPHONYLPIPERIDINE DERIVATIVES CONTAINING AN ARYL OR HETEROARYL GROUP FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2004-01-22 WO disclosed
EP-1228041-B1 INDOLE DERIVATIVES AND THEIR USE AS 5HT2A LIGANDS MERCK PATENT GMBH (DE) 2003-10-15 EP disclosed
CN-1003855-B Process for preparing 1, 3-disubstituted 2-oxindoles 美国辉瑞有限公司 1989-04-12 CN disclosed
CN-85101795-A With 1, the two 2-oxyindoles that replace of 3-prepare pain killer and antiphlogistic 1987-04-08 CN disclosed
US-4569942-A N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents PFIZER INC. (US) 1986-02-11 US disclosed